Zealand Pharma revenue and financials

ZEAL · Nasdaq Copenhagen · DKK

Compare Zealand Pharma
kr 209.80Change from previous close: −1.36%Absolute change: −kr 2.90

Close · November 20, 2026

In the fiscal year ended December 2025, Zealand Pharma reported revenue of kr 9.21B (+14,598.86% year over year). Net income was kr 6.46B, a net margin of 70.0%.

Annual revenue · 2025: kr 9.21B
  1. kr 230.86M2016
  2. kr 136.32M2017
  3. kr 37.98M2018
  4. kr 41.33M2019
  5. kr 192M2020
  6. kr 108.55M2021
  7. kr 103.99M2022
  8. kr 342.79M2023
  9. kr 62.69M2024
  10. kr 9.21B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+14,598.86%
2025 vs 2024
Net margin
70.0%
2024: -1,720.9%

How Zealand Pharma is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of DKK; per-share values in DKK; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue9,21562.734310410919241.338.0136231
Cost of revenue0.87.93.20.011.0—0.43.414.230.9
Gross profit9,21454.834010497.619240.934.6122200
Selling, general and administrative49640421625829822267.943.547.358.6
Research and development1,605920685614582596561438324262
Operating income6,917-1,269-561-817-782-626-588-447-249-119
EBIT6,917-1,269-561-817-782-626-588-447-249-119
EBITDA6,927-1,258-555-730-769-584-574-442-244-114
Interest expense29.134.025.857.84.149.33.233.424.740.5
Pre-tax income7,001-1,083-709-972-759-674-577625-280-163
Income tax546-4.6-5.1-6.4-3.9-4.8-5.143.8-5.5-5.5
Net income6,455-1,079-704-1,202-1,018-847-572581-274-157
Net income to common shareholders6,455-1,079-704-966-755-669-572581-274-157
Basic EPS91.56-16.24-12.44-20.90-17.61-17.43-16.9118.94-9.85-6.47
Diluted EPS90.22-16.24-12.44-20.90-17.61-17.43-16.9118.94-9.85-6.47
Average shares (basic)70.566.456.646.242.938.433.830.727.924.3
Average shares (diluted)71.566.456.646.242.938.433.830.727.924.3

Companies in the group: same industry, similar size